Revision as of 18:53, 17 February 2017 by en>Boghog(removed inappropriate underlinked tag (this article only contains one line of prose!); removed further reading citations not specific to this gene)
LIM domain only protein 3 is a transcription co-factor, which in humans is encoded by the LMO3gene.[1][2][3] LMO3 interacts with the tumor suppressor p53 and regulates its function.[4] LMO3 is considered to be an oncogene in Neuroblastoma.[5]
References
↑Larsen S, Yokochi T, Isogai E, Nakamura Y, Ozaki T, Nakagawara A (February 2010). "LMO3 interacts with p53 and inhibits its transcriptional activity". Biochemical and Biophysical Research Communications. 392 (3): 252–7. doi:10.1016/j.bbrc.2009.12.010. PMID19995558.
↑Shi J, Cai W, Chen X, Ying K, Zhang K, Xie Y (August 2001). "Identification of dopamine responsive mRNAs in glial cells by suppression subtractive hybridization". Brain Research. 910 (1–2): 29–37. doi:10.1016/S0006-8993(01)02393-9. PMID11489251.
↑Larsen S, Yokochi T, Isogai E, Nakamura Y, Ozaki T, Nakagawara A (February 2010). "LMO3 interacts with p53 and inhibits its transcriptional activity". Biochemical and Biophysical Research Communications. 392 (3): 252–7. doi:10.1016/j.bbrc.2009.12.010. PMID19995558.
↑Larsen S, Yokochi T, Isogai E, Nakamura Y, Ozaki T, Nakagawara A (February 2010). "LMO3 interacts with p53 and inhibits its transcriptional activity". Biochemical and Biophysical Research Communications. 392 (3): 252–7. doi:10.1016/j.bbrc.2009.12.010. PMID19995558.
Further reading
Friedel S, Saar K, Sauer S, Dempfle A, Walitza S, Renner T, Romanos M, Freitag C, et al. (October 2007). "Association and linkage of allelic variants of the dopamine transporter gene in ADHD". Molecular Psychiatry. 12 (10): 923–33. doi:10.1038/sj.mp.4001986. PMID17579611.
Davis C, Levitan RD, Kaplan AS, Carter J, Reid C, Curtis C, Patte K, Kennedy JL (October 2007). "Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder". Neuropsychopharmacology. 32 (10): 2199–206. doi:10.1038/sj.npp.1301348. PMID17314918.
Lim J, Hao T, Shaw C, Patel AJ, Szabó G, Rual JF, Fisk CJ, Li N, et al. (May 2006). "A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration". Cell. 125 (4): 801–14. doi:10.1016/j.cell.2006.03.032. PMID16713569.
Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, et al. (October 2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID16189514.
Aoyama M, Ozaki T, Inuzuka H, Tomotsune D, Hirato J, Okamoto Y, Tokita H, Ohira M, et al. (June 2005). "LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma". Cancer Research. 65 (11): 4587–97. doi:10.1158/0008-5472.CAN-04-4630. PMID15930276.
Foroni L, Boehm T, White L, Forster A, Sherrington P, Liao XB, Brannan CI, Jenkins NA, et al. (August 1992). "The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development". Journal of Molecular Biology. 226 (3): 747–61. doi:10.1016/0022-2836(92)90630-3. PMID1507224.
